Ozari Health has launched a new telehealth platform that makes GLP-1 weight loss medications more accessible and affordable across the United States. This service allows you to complete a brief online intake form and connect with licensed providers who can prescribe compounded medications like Semaglutide and Tirzepatide, starting at $86 and $120 per month, respectively. The platform also offers branded options such as Ozempic and Wegovy, all without hidden fees or long-term contracts.

This is significant for anyone looking to manage their weight effectively. Clinical trials have shown that these medications can lead to substantial weight loss—up to 20.9% over 72 weeks with Tirzepatide, and 20.2% with Semaglutide. However, the high cost of brand-name versions often puts them out of reach for many people. Ozari Health aims to bridge this gap by providing a straightforward, transparent service that simplifies the process of obtaining these medications.

The platform is in its early stages but is built on strong evidence from clinical trials demonstrating the effectiveness of GLP-1 medications. Ozari Health sets itself apart by offering personalized support throughout the treatment process, ensuring that patients have access to real people for assistance rather than automated systems. The service is fully online, HIPAA compliant, and partners with reputable pharmacies to ensure safety and quality.

If you’re considering weight loss options, Ozari Health may be a convenient choice to explore. Just remember that compounded medications are not FDA-approved, so it’s essential to weigh the benefits and risks before starting any new treatment.

Source: globenewswire.com